Jefferies Financial Group’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
Other funds holding ZNTL
SFCM
Jefferies Financial Group's ZNTL Position: Q3 2026 in Review
Jefferies Financial Group opened a new position in Zentalis Pharmaceuticals (ZNTL) in Q3 2026: 43,898 shares worth $122K. The stake represents ﹤0.01% of the portfolio and ranks #1167 among its holdings. This is a return to the name: Jefferies Financial Group previously reported a position in ZNTL as recently as Q2 2023.
Jefferies Financial Group first reported a position in ZNTL in Q2 2023 and has held it in 2 quarters since. The position peaked at $2.65M in Q2 2023. 127 funds tracked by Wall St. Rank hold ZNTL as of Q3 2026.
- Jefferies Financial Group held 43,898 shares of Zentalis Pharmaceuticals worth $122K as of Q3 2026.
- Zentalis Pharmaceuticals was a new Jefferies Financial Group position in Q3 2026.
- Zentalis Pharmaceuticals made up ﹤0.01% of Jefferies Financial Group's portfolio in Q3 2026, its #1167 holding.
- Jefferies Financial Group first reported a position in Zentalis Pharmaceuticals in Q2 2023 and has held it in 2 quarters since.
- Jefferies Financial Group's Zentalis Pharmaceuticals position peaked at $2.65M in Q2 2023.
- 127 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q3 2026.
Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.